{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T04:02:12Z","timestamp":1793937732301,"version":"4.8.0"},"reference-count":86,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2018,7,20]],"date-time":"2018-07-20T00:00:00Z","timestamp":1532044800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Diabetologia"],"published-print":{"date-parts":[[2018,9]]},"DOI":"10.1007\/s00125-018-4692-1","type":"journal-article","created":{"date-parts":[[2018,7,20]],"date-time":"2018-07-20T01:52:42Z","timestamp":1532051562000},"page":"1902-1912","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":564,"title":["Neurodegeneration in diabetic retinopathy: does it really matter?"],"prefix":"10.1007","volume":"61","author":[{"given":"Rafael","family":"Sim\u00f3","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alan W.","family":"Stitt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas W.","family":"Gardner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,7,20]]},"reference":[{"key":"4692_CR1","doi-asserted-by":"publisher","first-page":"556","DOI":"10.2337\/dc11-1909","volume":"35","author":"JW Yau","year":"2012","unstructured":"Yau JW, Rogers SL, Kawasaki R et al (2012) Global prevalence and major risk factors of diabetic retinopathy. Diabetes Care 35:556\u2013564","journal-title":"Diabetes Care"},{"key":"4692_CR2","doi-asserted-by":"publisher","first-page":"1643","DOI":"10.2337\/dc15-2171","volume":"39","author":"JL Leasher","year":"2016","unstructured":"Leasher JL, Bourne RR, Flaxman SR et al (2016) Global estimates on the number of people blind or visually impaired by diabetic retinopathy: a meta-analysis from 1990 to 2010. Diabetes Care 39:1643\u20131649","journal-title":"Diabetes Care"},{"key":"4692_CR3","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1111\/nyas.12412","volume":"1311","author":"SF Abcouwer","year":"2014","unstructured":"Abcouwer SF, Gardner TW (2014) Diabetic retinopathy: loss of neuroretinal adaptation to the diabetic metabolic environment. Ann N Y Acad Sci 1311:174\u2013190","journal-title":"Ann N Y Acad Sci"},{"key":"4692_CR4","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/j.tem.2013.09.005","volume":"25","author":"R Sim\u00f3","year":"2014","unstructured":"Sim\u00f3 R, Hern\u00e1ndez C (2014) Neurodegeneration in the diabetic eye: new insights and therapeutic perspectives. Trends Endocrinol Metab 25:23\u201333","journal-title":"Trends Endocrinol Metab"},{"key":"4692_CR5","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1016\/j.preteyeres.2015.04.003","volume":"48","author":"R Sim\u00f3","year":"2015","unstructured":"Sim\u00f3 R, Hern\u00e1ndez C (2015) Novel approaches for treating diabetic retinopathy based on recent pathogenic evidence. Prog Retin Eye Res 48:160\u2013180","journal-title":"Prog Retin Eye Res"},{"key":"4692_CR6","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1016\/j.preteyeres.2015.08.001","volume":"51","author":"AW Stitt","year":"2016","unstructured":"Stitt AW, Curtis TM, Chen M et al (2016) The progress in understanding and treatment of diabetic retinopathy. Prog Retin Eye Res 51:156\u2013186","journal-title":"Prog Retin Eye Res"},{"key":"4692_CR7","doi-asserted-by":"publisher","first-page":"412","DOI":"10.2337\/dc16-2641","volume":"40","author":"SD Solomon","year":"2017","unstructured":"Solomon SD, Chew E, Duh EJ et al (2017) Diabetic retinopathy: a position statement by the American Diabetes Association. Diabetes Care 40:412\u2013418","journal-title":"Diabetes Care"},{"key":"4692_CR8","doi-asserted-by":"publisher","first-page":"859","DOI":"10.2337\/diacare.25.5.859","volume":"25","author":"P Rossing","year":"2002","unstructured":"Rossing P, Hougaard P, Parving HH (2002) Risk factors for development of incipient and overt diabetic nephropathy in type 1 diabetic patients. A 10-year prospective observational study. Diabetes Care 25:859\u2013864","journal-title":"Diabetes Care"},{"key":"4692_CR9","doi-asserted-by":"publisher","first-page":"1354","DOI":"10.1111\/dme.12793","volume":"32","author":"M Takagi","year":"2015","unstructured":"Takagi M, Babazono T, Uchigata Y (2015) Differences in risk factors for the onset of albuminuria and decrease in glomerular filtration rate in people with type 2 diabetes mellitus: implications for the pathogenesis of diabetic kidney disease. Diabet Med 32:1354\u20131360","journal-title":"Diabet Med"},{"key":"4692_CR10","doi-asserted-by":"publisher","first-page":"1238","DOI":"10.2337\/dc11-0079","volume":"34","author":"CK Kramer","year":"2011","unstructured":"Kramer CK, Rodrigues TC, Canani LH, Gross JL, Azevedo MJ (2011) Diabetic retinopathy predicts all-cause mortality and cardiovascular events in both type 1 and type 2 diabetes: meta-analysis of observational studies. Diabetes Care 34:1238\u20131244","journal-title":"Diabetes Care"},{"key":"4692_CR11","doi-asserted-by":"publisher","first-page":"1266","DOI":"10.2337\/dc12-1311","volume":"36","author":"HC Gerstein","year":"2013","unstructured":"Gerstein HC, Ambrosious WT, Danis R et al (2013) Diabetic retinopathy, its progression, and incident cardiovascular events in the ACCORD trial. Diabetes Care 36:1266\u20131271","journal-title":"Diabetes Care"},{"key":"4692_CR12","doi-asserted-by":"publisher","first-page":"588","DOI":"10.1016\/S2213-8587(16)30057-2","volume":"4","author":"JR Brownrigg","year":"2016","unstructured":"Brownrigg JR, Hughes CO, Burleigh D et al (2016) Microvascular disease and risk of cardiovascular events among individuals with type 2 diabetes: a population-level cohort study. Lancet Diabetes Endocrinol 4:588\u2013597","journal-title":"Lancet Diabetes Endocrinol"},{"key":"4692_CR13","doi-asserted-by":"publisher","first-page":"398","DOI":"10.1161\/01.STR.0000254547.91276.50","volume":"38","author":"N Cheung","year":"2007","unstructured":"Cheung N, Rogera S, Couper DJ, Klein R, Sharrett AR, Wong TY (2007) Is diabetic retinopathy an independent risk factor for ischemic stroke? Stroke 38:398\u2013401","journal-title":"Stroke"},{"key":"4692_CR14","doi-asserted-by":"publisher","first-page":"574","DOI":"10.1016\/j.ophtha.2012.08.029","volume":"120","author":"R Kawasaki","year":"2013","unstructured":"Kawasaki R, Tanaka S, Tanaka S et al (2013) Risk of cardiovascular diseases is increased even with mild diabetic retinopathy: the Japan Diabetes Complications Study. Ophthalmology 120:574\u2013582","journal-title":"Ophthalmology"},{"key":"4692_CR15","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1097\/IAE.0b013e3181884f2d","volume":"29","author":"JK Schmier","year":"2009","unstructured":"Schmier JK, Covert DW, Lau EC, Matthews GP (2009) Medicare expenditures associated with diabetes and diabetic retinopathy. Retina 29:199\u2013206","journal-title":"Retina"},{"key":"4692_CR16","doi-asserted-by":"publisher","first-page":"2147","DOI":"10.1007\/s00125-010-1836-3","volume":"53","author":"E Heinz","year":"2010","unstructured":"Heinz E, Wirehn AB, Peebo BB, Rosenqvist U, Levin LA (2010) Prevalence and healthcare costs of diabetic retinopathy: a population-based register study in Sweden. Diabetologia 53:2147\u20132154","journal-title":"Diabetologia"},{"key":"4692_CR17","doi-asserted-by":"publisher","first-page":"e0180949","DOI":"10.1371\/journal.pone.0180949","volume":"12","author":"X Zhang","year":"2017","unstructured":"Zhang X, Low S, Kumari N et al (2017) Direct medical cost associated with retinopathy severity in type 2 diabetes in Singapore. PLoS One 12:e0180949","journal-title":"PLoS One"},{"key":"4692_CR18","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1124\/pr.57.2.4","volume":"57","author":"BT Hawkins","year":"2005","unstructured":"Hawkins BT, Davis TP (2005) The blood-brain barrier\/neurovascular unit in health and disease. Pharmacol Rev 57:173\u2013185","journal-title":"Pharmacol Rev"},{"key":"4692_CR19","doi-asserted-by":"publisher","first-page":"1227","DOI":"10.1056\/NEJMra1005073","volume":"366","author":"DA Antonetti","year":"2012","unstructured":"Antonetti DA, Klein R, Gardner TW (2012) Diabetic retinopathy. N Engl J Med 366:1227\u20131239","journal-title":"N Engl J Med"},{"key":"4692_CR20","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s00417-016-3548-y","volume":"255","author":"TW Gardner","year":"2017","unstructured":"Gardner TW, Davila JR (2017) The neurovascular unit and the pathophysiologic basis of diabetic retinopathy. Graefes Arch Clin Exp Ophthalmol 255:1\u20136","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"4692_CR21","doi-asserted-by":"publisher","first-page":"e93751","DOI":"10.1172\/jci.insight.93751","volume":"2","author":"EJ Duh","year":"2017","unstructured":"Duh EJ, Sun JK, Stitt AW (2017) Diabetic retinopathy: current understanding, mechanisms, and treatment strategies. JCI Insight 2:e93751","journal-title":"JCI Insight"},{"key":"4692_CR22","doi-asserted-by":"publisher","first-page":"1685","DOI":"10.1038\/jcbfm.2013.145","volume":"33","author":"EA Newman","year":"2013","unstructured":"Newman EA (2013) Functional hyperemia and mechanisms of neurovascular coupling in the retinal vasculature. J Cereb Blood Flow Metab 33:1685\u20131695","journal-title":"J Cereb Blood Flow Metab"},{"key":"4692_CR23","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1113\/expphysiol.2006.036376","volume":"92","author":"MR Metea","year":"2007","unstructured":"Metea MR, Newmman EA (2007) Signalling within the neurovascular unit in the retina. Exp Physiol 92:635\u2013640","journal-title":"Exp Physiol"},{"key":"4692_CR24","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1007\/s11892-017-0909-9","volume":"17","author":"T Bek","year":"2017","unstructured":"Bek T (2017) Diameter changes of retinal vessels in diabetic retinopathy. Curr Diab Rep 17:82","journal-title":"Curr Diab Rep"},{"key":"4692_CR25","doi-asserted-by":"publisher","first-page":"e434","DOI":"10.1111\/j.1755-3768.2012.02445.x","volume":"90","author":"ME Lott","year":"2012","unstructured":"Lott ME, Slocomb JE, Shivkumar V et al (2012) Comparison of retinal vasodilator and constrictor responses in type 2 diabetes. Acta Ophthalmol 90:e434\u2013e441","journal-title":"Acta Ophthalmol"},{"key":"4692_CR26","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1016\/j.visres.2017.05.009","volume":"139","author":"M D\u00edaz-Cor\u00e1nguez","year":"2017","unstructured":"D\u00edaz-Cor\u00e1nguez M, Ramos C, Antonetti DA (2017) The inner blood-retinal barrier: cellular basis and development. Vis Res 139:123\u2013137","journal-title":"Vis Res"},{"key":"4692_CR27","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/j.preteyeres.2013.02.001","volume":"34","author":"I Klaassen","year":"2013","unstructured":"Klaassen I, Van Noorden CJ, Schlingemann RO (2013) Molecular basis of the inner blood-retinal barrier and its breakdown in diabetic macular edema and other pathological conditions. Prog Retin Eye Res 34:19\u201348","journal-title":"Prog Retin Eye Res"},{"key":"4692_CR28","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1016\/j.preteyeres.2011.05.002","volume":"30","author":"J Tang","year":"2011","unstructured":"Tang J, Kern TS (2011) Inflammation in diabetic retinopathy. Prog Retin Eye Res 30:343\u2013358","journal-title":"Prog Retin Eye Res"},{"key":"4692_CR29","doi-asserted-by":"publisher","first-page":"6565","DOI":"10.1167\/iovs.15-16854","volume":"56","author":"Y Xu","year":"2015","unstructured":"Xu Y, Cheng Q, Yang B et al (2015) Increased sCD200 levels in vitreous of patients with proliferative diabetic retinopathy and its correlation with VEGF and proinflammatory cytokines. Invest Ophthalmol Vis Sci 56:6565\u20136572","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"4692_CR30","doi-asserted-by":"publisher","first-page":"743","DOI":"10.1001\/archopht.122.5.743","volume":"122","author":"A Cant\u00f3n","year":"2004","unstructured":"Cant\u00f3n A, Martinez-C\u00e1ceres EM, Hern\u00e1ndez C, Espejo C, Garc\u00eda-Arum\u00ed J, Sim\u00f3 R (2004) CD4-CD8 and CD28 expression in T cells infiltrating the vitreous fluid in patients with proliferative diabetic retinopathy: a flow cytometric analysis. Arch Ophthalmol 122:743\u2013749","journal-title":"Arch Ophthalmol"},{"key":"4692_CR31","doi-asserted-by":"publisher","first-page":"752","DOI":"10.1016\/j.biocel.2005.08.002","volume":"38","author":"JL Wilkinson-Berka","year":"2006","unstructured":"Wilkinson-Berka JL (2006) Angiotensin and diabetic retinopathy. Int J Biochem Cell Biol 38:752\u2013765","journal-title":"Int J Biochem Cell Biol"},{"key":"4692_CR32","doi-asserted-by":"publisher","first-page":"2191","DOI":"10.2337\/db07-1281","volume":"57","author":"T Kurihara","year":"2008","unstructured":"Kurihara T, Ozawa Y, Nagai N et al (2008) Angiotensin II type 1 receptor signaling contributes to synaptophysin degradation and neuronal dysfunction in the diabetic retina. Diabetes 57:2191\u20132198","journal-title":"Diabetes"},{"key":"4692_CR33","doi-asserted-by":"publisher","first-page":"1382","DOI":"10.2337\/db09-0166","volume":"58","author":"KC Silva","year":"2009","unstructured":"Silva KC, Rosales MA, Biswas SK, Lopes de Faria JB, Lopes de Faria JM (2009) Diabetic retinal neurodegeneration is associated with mitochondrial oxidative stress and is improved by an angiotensin receptor blocker in a model combining hypertension and diabetes. Diabetes 58:1382\u20131390","journal-title":"Diabetes"},{"key":"4692_CR34","doi-asserted-by":"publisher","first-page":"1572","DOI":"10.1007\/s11064-013-1058-4","volume":"38","author":"MS Ola","year":"2013","unstructured":"Ola MS, Ahmed MM, Abouhashish HM, Al-Rejaie SS, Alhomida AS (2013) Telmisartan ameliorates neurotrophic support and oxidative stress in the retina of streptozotocin-induced diabetic rats. Neurochem Res 38:1572\u20131579","journal-title":"Neurochem Res"},{"key":"4692_CR35","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1016\/j.exer.2014.08.011","volume":"133","author":"S Roy","year":"2015","unstructured":"Roy S, Bae E, Amin S, Kim D (2015) Extracellular matrix, gap junctions, and retinal vascular homeostasis in diabetic retinopathy. Exp Eye Res 133:58\u201368","journal-title":"Exp Eye Res"},{"key":"4692_CR36","doi-asserted-by":"publisher","first-page":"86","DOI":"10.2337\/diabetes.55.01.06.db05-0186","volume":"55","author":"T Oshitari","year":"2006","unstructured":"Oshitari T, Polewski M, Chadda M, Li AF, Sato T, Roy S (2006) Effect of combined antisense oligonucleotides against high-glucose- and diabetes-induced overexpression of extracellular matrix components and increased vascular permeability. Diabetes 55:86\u201392","journal-title":"Diabetes"},{"key":"4692_CR37","doi-asserted-by":"publisher","first-page":"20","DOI":"10.3389\/fncel.2016.00020","volume":"10","author":"A Trost","year":"2016","unstructured":"Trost A, Lange S, Schroedl F et al (2016) Brain and retinal pericytes: origin, function and role. Front Cell Neurosci 10:20","journal-title":"Front Cell Neurosci"},{"key":"4692_CR38","doi-asserted-by":"publisher","first-page":"2495","DOI":"10.2337\/db08-0325","volume":"57","author":"F Pfister","year":"2008","unstructured":"Pfister F, Feng Y, vom Hagen F et al (2008) Pericyte migration: a novel mechanism of pericyte loss in experimental diabetic retinopathy. Diabetes 57:2495\u20132502","journal-title":"Diabetes"},{"key":"4692_CR39","doi-asserted-by":"publisher","first-page":"9","DOI":"10.2337\/db10-0454","volume":"60","author":"HP Hammes","year":"2011","unstructured":"Hammes HP, Feng Y, Pfister F, Brownlee M (2011) Diabetic retinopathy: targeting vasoregression. Diabetes 60:9\u201316","journal-title":"Diabetes"},{"key":"4692_CR40","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1007\/s00125-017-4435-8","volume":"61","author":"HP Hammes","year":"2018","unstructured":"Hammes HP (2018) Diabetic retinopathy: hyperglycemia, oxidative stress and beyond. Diabetologia 61:29\u201338","journal-title":"Diabetologia"},{"key":"4692_CR41","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1016\/j.devcel.2015.06.004","volume":"34","author":"C Korn","year":"2015","unstructured":"Korn C, Augustin HG (2015) Mechanisms of vessel pruning and regression. Dev Cell 34:5\u201317","journal-title":"Dev Cell"},{"key":"4692_CR42","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.preteyeres.2017.11.003","volume":"64","author":"RF Spaide","year":"2018","unstructured":"Spaide RF, Fujimoto JG, Waheed NK, Sadda SR, Staurenghi G (2018) Optical coherence tomography angiography. Prog Retin Eye Res 64:1\u201355","journal-title":"Prog Retin Eye Res"},{"key":"4692_CR43","doi-asserted-by":"publisher","first-page":"OCT348","DOI":"10.1167\/iovs.15-18782","volume":"57","author":"N Hasegawa","year":"2016","unstructured":"Hasegawa N, Nozaki M, Takase N, Yoshida M, Ogura Y (2016) New insights into microaneurysms in the deep capillary plexus detected by optical coherence tomography angiography in diabetic macular edema. Invest Ophthalmol Vis Sci 57:OCT348\u2013OCT355","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"4692_CR44","doi-asserted-by":"publisher","first-page":"783","DOI":"10.1172\/JCI2425","volume":"102","author":"AJ Barber","year":"1998","unstructured":"Barber AJ, Lieth E, Khin SA, Antonetti DA, Buchanan AG, Gardner TW (1998) Neural apoptosis in the retina during experimental and human diabetes. Early onset and effect of insulin. J Clin Invest 102:783\u2013791","journal-title":"J Clin Invest"},{"key":"4692_CR45","doi-asserted-by":"publisher","first-page":"2902","DOI":"10.2337\/dc07-0332","volume":"30","author":"E Carrasco","year":"2007","unstructured":"Carrasco E, Hern\u00e1ndez C, Miralles A, Huguet P, Farr\u00e9s J, Sim\u00f3 R (2007) Lower somatostatin expression is an early event in diabetic retinopathy and is associated with retinal neurodegeneration. Diabetes Care 30:2902\u20132908","journal-title":"Diabetes Care"},{"key":"4692_CR46","doi-asserted-by":"publisher","first-page":"2633","DOI":"10.1007\/s00125-009-1548-8","volume":"52","author":"M Garcia-Ram\u00edrez","year":"2009","unstructured":"Garcia-Ram\u00edrez M, Hern\u00e1ndez C, Villarroel M et al (2009) Interphotoreceptor retinoid-binding protein (IRBP) is downregulated at early stages of diabetic retinopathy. Diabetologia 52:2633\u20132641","journal-title":"Diabetologia"},{"key":"4692_CR47","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1159\/000450958","volume":"57","author":"S Sim\u00e3o","year":"2017","unstructured":"Sim\u00e3o S, Costa M\u00c2, Sun JK, Cunha-Vaz J, Sim\u00f3 R (2017) Development of a normative database for multifocal electroretinography in the context of a multicenter clinical trial. Ophthalmic Res 57:107\u2013117","journal-title":"Ophthalmic Res"},{"key":"4692_CR48","doi-asserted-by":"publisher","first-page":"380","DOI":"10.1007\/s11892-010-0132-4","volume":"10","author":"GR Jackson","year":"2010","unstructured":"Jackson GR, Barber AJ (2010) Visual dysfunction associated with diabetic retinopathy. Curr Diab Rep 10:380\u2013384","journal-title":"Curr Diab Rep"},{"key":"4692_CR49","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1007\/s10633-014-9476-4","volume":"130","author":"BE Wolff","year":"2015","unstructured":"Wolff BE, Bearse MA Jr, Schneck ME et al (2015) Color vision and neuroretinal function in diabetes. Doc Ophthalmol 130:131\u2013139","journal-title":"Doc Ophthalmol"},{"key":"4692_CR50","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1007\/s12020-016-1097-0","volume":"57","author":"M Trento","year":"2017","unstructured":"Trento M, Durando O, Lavecchia S et al (2017) Vision related quality of life in patients with type 2 diabetes in the EUROCONDOR trial. Endocrine 57:83\u201388","journal-title":"Endocrine"},{"key":"4692_CR51","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1159\/000328979","volume":"227","author":"A Bringmann","year":"2012","unstructured":"Bringmann A, Wiedeman P (2012) M\u00fcller glial cells in retinal disease. Ophthalmologica 227:1\u201319","journal-title":"Ophthalmologica"},{"key":"4692_CR52","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1111\/j.1444-0938.2012.00741.x","volume":"95","author":"NJ Coorey","year":"2012","unstructured":"Coorey NJ, Shen W, Chung SH, Zhu L, Gillies MC (2012) The role of glia in retinal vascular disease. Clin Exp Optom 95:266\u2013281","journal-title":"Clin Exp Optom"},{"key":"4692_CR53","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1007\/s00592-017-0984-z","volume":"54","author":"AI Arroba","year":"2017","unstructured":"Arroba AI, Valverde AM (2017) Modulation of microglia in the retina: new insights into diabetic retinopathy. Acta Diabetol 54:527\u2013533","journal-title":"Acta Diabetol"},{"key":"4692_CR54","doi-asserted-by":"publisher","first-page":"110","DOI":"10.3390\/ijms19010110","volume":"19","author":"C Altmann","year":"2018","unstructured":"Altmann C, Schmidt MHH (2018) The role of microglia in diabetic retinopathy: inflammation, microvascular defects and neurodegeneration. Int J Mol Sci 19:110","journal-title":"Int J Mol Sci"},{"key":"4692_CR55","doi-asserted-by":"publisher","first-page":"e26498","DOI":"10.1371\/journal.pone.0026498","volume":"6","author":"PE Fort","year":"2011","unstructured":"Fort PE, Losiewicz MK, Reiter CE et al (2011) Differential roles of hyperglycemia and hypoinsulinemia in diabetes induced retinal cell death: evidence for retinal insulin resistance. PLoS One 6:e26498","journal-title":"PLoS One"},{"key":"4692_CR56","first-page":"221","volume":"6","author":"X Liu","year":"2013","unstructured":"Liu X, Chen HH, Zhang LW (2013) Potential therapeutic effects of pigment epithelium-derived factor for treatment of diabetic retinopathy. Int J Ophthalmol 6:221\u2013227","journal-title":"Int J Ophthalmol"},{"key":"4692_CR57","doi-asserted-by":"publisher","first-page":"699","DOI":"10.1007\/978-3-319-17121-0_93","volume":"854","author":"F Polato","year":"2016","unstructured":"Polato F, Becerra SP (2016) Pigment epithelium-derived factor, a protective factor for photoreceptors in vivo. Adv Exp Med Biol 854:699\u2013706","journal-title":"Adv Exp Med Biol"},{"key":"4692_CR58","doi-asserted-by":"publisher","first-page":"2569","DOI":"10.2337\/db12-0926","volume":"62","author":"C Hern\u00e1ndez","year":"2013","unstructured":"Hern\u00e1ndez C, Garc\u00eda-Ram\u00edrez M, Corraliza L et al (2013) Topical administration of somatostatin prevents retinal neurodegeneration in experimental diabetes. Diabetes 62:2569\u20132578","journal-title":"Diabetes"},{"key":"4692_CR59","doi-asserted-by":"crossref","first-page":"172","DOI":"10.2337\/db15-0443","volume":"65","author":"C Hern\u00e1ndez","year":"2016","unstructured":"Hern\u00e1ndez C, Bogdanov P, Corraliza L et al (2016) Topical administration of GLP-1 receptor agonists prevents retinal neurodegeneration in experimental diabetes. Diabetes 65:172\u2013187","journal-title":"Diabetes"},{"key":"4692_CR60","doi-asserted-by":"publisher","first-page":"1453","DOI":"10.2337\/db16-1364","volume":"66","author":"R Sim\u00f3","year":"2017","unstructured":"Sim\u00f3 R, Hern\u00e1ndez C (2017) GLP-1R as a target for the treatment of diabetic retinopathy: friend or foe? Diabetes 66:1453\u20131460","journal-title":"Diabetes"},{"key":"4692_CR61","doi-asserted-by":"publisher","first-page":"2285","DOI":"10.1007\/s00125-017-4388-y","volume":"60","author":"C Hern\u00e1ndez","year":"2017","unstructured":"Hern\u00e1ndez C, Bogdanov P, Sol\u00e0-Adell C et al (2017) Topical administration of DPP-IV inhibitors prevents retinal neurodegeneration in experimental diabetes. Diabetologia 60:2285\u20132298","journal-title":"Diabetologia"},{"key":"4692_CR62","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1016\/j.exer.2012.01.006","volume":"96","author":"TA Sullivan","year":"2012","unstructured":"Sullivan TA, Geisert EE, Templeton JP, Rex TS (2012) Dose-dependent treatment of optic nerve crush by exogenous systemic mutant erythropoietin. Exp Eye Res 96:36\u201341","journal-title":"Exp Eye Res"},{"key":"4692_CR63","doi-asserted-by":"publisher","first-page":"e102013","DOI":"10.1371\/journal.pone.0102013","volume":"9","author":"S Busch","year":"2014","unstructured":"Busch S, Kannt A, Kolibabka M et al (2014) Systemic treatment with erythropoietin protects the neurovascular unit in a rat model of retinal neurodegeneration. PLoS One 9:e102013","journal-title":"PLoS One"},{"issue":"Suppl1","key":"4692_CR64","first-page":"S55","volume":"60","author":"R Sim\u00f3","year":"2017","unstructured":"Sim\u00f3 R, Bandello F, Egan C et al (2017) Topical administration of somatostatin and brimonidine in the early stages of diabetic retinopathy: results of the EUROCONDOR study. Diabetologia 60(Suppl1):S55 Abstract","journal-title":"Diabetologia"},{"key":"4692_CR65","doi-asserted-by":"publisher","first-page":"773","DOI":"10.1007\/s001250051375","volume":"43","author":"JA Juan De","year":"2000","unstructured":"De Juan JA, Moya FJ, Ripodas A, Bernal R, Fernandez-Cruz A, Fernandez-Durango R (2000) Changes in the density and localisation of endothelin receptors in the early stages of rat diabetic retinopathy and the effect of insulin treatment. Diabetologia 43:773\u2013785","journal-title":"Diabetologia"},{"key":"4692_CR66","doi-asserted-by":"publisher","first-page":"2516","DOI":"10.1167\/iovs.13-13676","volume":"55","author":"JC Chou","year":"2014","unstructured":"Chou JC, Rollins SD, Ye M, Batlle D, Fawzi AA (2014) Endothelin receptor-A antagonist attenuates retinal vascular and neuroretinal pathology in diabetic mice. Invest Ophthalmol Vis Sci 55:2516\u20132525","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"4692_CR67","doi-asserted-by":"publisher","first-page":"e43199","DOI":"10.1371\/journal.pone.0043199","volume":"7","author":"AZ Minton","year":"2012","unstructured":"Minton AZ, Phatak NR, Stankowska DL et al (2012) Endothelin B receptors contribute to retinal ganglion cell loss in a rat model of glaucoma. PLoS One 7:e43199","journal-title":"PLoS One"},{"key":"4692_CR68","doi-asserted-by":"publisher","first-page":"3490","DOI":"10.1167\/iovs.11-9415","volume":"8","author":"M Tonari","year":"2012","unstructured":"Tonari M, Kurimoto T, Horie T, Sugiyama T, Ikeda T, Oku H (2012) Blocking endothelin-B receptors rescues retinal ganglion cells from optic nerve injury through suppression of neuroinflammation. Invest Ophthalmol Vis Sci 8:3490\u20133500","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"4692_CR69","doi-asserted-by":"publisher","first-page":"16586","DOI":"10.1073\/pnas.1314575110","volume":"110","author":"Y Du","year":"2013","unstructured":"Du Y, Veenstra A, Palczewski K, Kern TS (2013) Photoreceptor cells are major contributors to diabetes-induced oxidative stress and local inflammation in the retina. Proc Natl Acad Sci U S A 110:16586\u201316591","journal-title":"Proc Natl Acad Sci U S A"},{"key":"4692_CR70","doi-asserted-by":"publisher","first-page":"4272","DOI":"10.1167\/iovs.16-19415","volume":"57","author":"H Liu","year":"2016","unstructured":"Liu H, Tang J, Duh Y et al (2016) Photoreceptor cells influence retinal vascular degeneration in mouse models of retinal degeneration and diabetes. Invest Ophthalmol Vis Sci 57:4272\u20134281","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"4692_CR71","doi-asserted-by":"publisher","first-page":"2111","DOI":"10.1007\/s00125-017-4381-5","volume":"60","author":"D Tonade","year":"2017","unstructured":"Tonade D, Liu H, Palczewski K, Kern TS (2017) Photoreceptor cells produce inflammatory products that contribute to retinal vascular permeability in a mouse model of diabetes. Diabetologia 60:2111\u20132120","journal-title":"Diabetologia"},{"key":"4692_CR72","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1016\/j.cmet.2013.09.003","volume":"18","author":"A Cerani","year":"2013","unstructured":"Cerani A, Tetreault N, Menard C et al (2013) Neuron-derived semaphorin 3A is an early inducer of vascular permeability in diabetic retinopathy via neuropilin-1. Cell Metab 18:505\u2013518","journal-title":"Cell Metab"},{"key":"4692_CR73","doi-asserted-by":"publisher","first-page":"1285","DOI":"10.1136\/bjophthalmol-2012-302005","volume":"96","author":"R Sim\u00f3","year":"2012","unstructured":"Sim\u00f3 R, Hern\u00e1ndez C (2012) Neurodegeneration is an early event in diabetic retinopathy: therapeutic implications. Br J Ophthalmol 96:1285\u20131290","journal-title":"Br J Ophthalmol"},{"key":"4692_CR74","doi-asserted-by":"publisher","first-page":"3926","DOI":"10.2337\/db13-1673","volume":"63","author":"A Reis","year":"2014","unstructured":"Reis A, Mateus C, Melo P, Figueira J, Cunha-Vaz J, Castelo-Branco M (2014) Neuroretinal dysfunction with intact blood-retinal barrier and absent vasculopathy in type 1 diabetes. Diabetes 63:3926\u20133937","journal-title":"Diabetes"},{"key":"4692_CR75","doi-asserted-by":"publisher","first-page":"e97302","DOI":"10.1371\/journal.pone.0097302","volume":"9","author":"P Bogdanov","year":"2014","unstructured":"Bogdanov P, Corraliza L, Villena JA et al (2014) The db\/db mouse: a useful model for the study of diabetic retinal neurodegeneration. PLoS One 9:e97302","journal-title":"PLoS One"},{"key":"4692_CR76","doi-asserted-by":"publisher","first-page":"E2655","DOI":"10.1073\/pnas.1522014113","volume":"113","author":"EH Sohn","year":"2016","unstructured":"Sohn EH, van Dijk HW, Jiao C et al (2016) Retinal neurodegeneration may precede microvascular changes characteristic of diabetic retinopathy in diabetes mellitus. Proc Natl Acad Sci U S A 113:E2655\u2013E2664","journal-title":"Proc Natl Acad Sci U S A"},{"key":"4692_CR77","doi-asserted-by":"publisher","first-page":"772","DOI":"10.1167\/iovs.10-5931","volume":"52","author":"WW Harrison","year":"2011","unstructured":"Harrison WW, Bearse MA Jr, Ng JS et al (2011) Multifocal electroretinograms predict onset of diabetic retinopathy in adult patients with diabetes. Invest Ophthalmol Vis Sci 52:772\u2013777","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"4692_CR78","doi-asserted-by":"publisher","first-page":"1622","DOI":"10.1167\/iovs.07-1157","volume":"49","author":"JS Ng","year":"2008","unstructured":"Ng JS, Bearse MA Jr, Schneck ME, Barez S, Adams AJ (2008) Local diabetic retinopathy prediction by multifocal ERG delays over 3 years. Invest Ophthalmol Vis Sci 49:1622\u20131628","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"4692_CR79","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1167\/iovs.17-21873","volume":"59","author":"MD Abramoff","year":"2018","unstructured":"Abramoff MD, Fort P, Han IC, Jayasundera KT, Sohn EH, Gardner TW (2018) Approach for clinically useful comprehensive classification of vascular and neural aspects of diabetic retinal disease. Invest Ophthalmol Vis Sci 59:519\u2013527","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"4692_CR80","doi-asserted-by":"publisher","first-page":"2503","DOI":"10.2337\/db16-1453","volume":"66","author":"AR Santos","year":"2017","unstructured":"Santos AR, Ribeiro L, Bandello F et al (2017) Functional and structural findings of neurodegeneration in early stages of diabetic retinopathy: cross-sectional analyses of baseline data of the EUROCONDOR project. Diabetes 66:2503\u20132510","journal-title":"Diabetes"},{"key":"4692_CR81","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1007\/s00592-017-0970-5","volume":"54","author":"R Sim\u00f3","year":"2017","unstructured":"Sim\u00f3 R, Ciudin A, Sim\u00f3-Servat O, Hern\u00e1ndez C (2017) Cognitive impairment and dementia: a new emerging complication of type 2 diabetes\u2014the diabetologist\u2019s perspective. Acta Diabetol 54:417\u2013424","journal-title":"Acta Diabetol"},{"key":"4692_CR82","doi-asserted-by":"publisher","first-page":"2264","DOI":"10.1167\/iovs.17-23678","volume":"59","author":"JM Sundstrom","year":"2018","unstructured":"Sundstrom JM, Hern\u00e1ndez C, Weber S et al (2018) Proteomic analysis of early diabetic retinopathy reveals mediators of neurodegenerative brain diseases. Invest Ophthamol Vis Sci 59:2264\u20132274","journal-title":"Invest Ophthamol Vis Sci"},{"key":"4692_CR83","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1016\/j.preteyeres.2017.01.001","volume":"57","author":"CY Cheung","year":"2017","unstructured":"Cheung CY, Ikram MK, Chen C, Wong TY (2017) Imaging retina to study dementia and stroke. Prog Retin Eye Res 57:89\u2013107","journal-title":"Prog Retin Eye Res"},{"key":"4692_CR84","doi-asserted-by":"publisher","first-page":"3098","DOI":"10.2337\/db17-0382","volume":"66","author":"A Ciudin","year":"2017","unstructured":"Ciudin A, Sim\u00f3-Servat O, Hern\u00e1ndez C et al (2017) Retinal microperimetry: a new tool for identifying patients with type 2 diabetes at risk for developing Alzheimer disease. Diabetes 66:3098\u20133104","journal-title":"Diabetes"},{"issue":"Suppl 1","key":"4692_CR85","first-page":"S3","volume":"36","author":"American Diabetes Association","year":"2013","unstructured":"American Diabetes Association (2013) Clinical practice recommendations. Diabetes Care 36(Suppl 1):S3","journal-title":"Diabetes Care"},{"key":"4692_CR86","first-page":"1496","volume":"14","author":"E Carrasco","year":"2008","unstructured":"Carrasco E, Hern\u00e1ndez C, de Torres I, Farr\u00e9s J, Sim\u00f3 R (2008) Lowered cortistatin expression is an early event in the human diabetic retina and is associated with apoptosis and glial activation. Mol Vis 14:1496\u20131502","journal-title":"Mol Vis"}],"container-title":["Diabetologia"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00125-018-4692-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00125-018-4692-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00125-018-4692-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,8,27]],"date-time":"2022-08-27T19:15:28Z","timestamp":1661627728000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00125-018-4692-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,7,20]]},"references-count":86,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2018,9]]}},"alternative-id":["4692"],"URL":"https:\/\/doi.org\/10.1007\/s00125-018-4692-1","relation":{},"ISSN":["0012-186X","1432-0428"],"issn-type":[{"value":"0012-186X","type":"print"},{"value":"1432-0428","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,7,20]]},"assertion":[{"value":"4 April 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 June 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 July 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare that there is no duality of interest associated with this manuscript.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Duality of interest"}}]}}